arrow
J

Jack Bartram

Great Ormond Street Hospital
H指数:26
被引数:3,002

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Rapid Whole Genome Sequencing Enhances Pediatric Cancer Diagnosis

快速全基因组测序增强儿科癌症诊断

2026-10-060
OAAI
A phase 1 feasibility trial of BE-CAR33, an “off-the-shelf” base-edited CAR33 T cell therapy for acute myeloid leukemia

BE-CAR33的“现成”碱基编辑CAR33 T细胞疗法治疗急性髓性白血病的1期可行性试验

2026-08-190
PRE
Single cell transcriptional evolution of myeloid leukemia of Down syndrome

唐氏综合征髓系白血病的单细胞转录演化

2026-04-230
OAAI
A non-canonical lymphoblast in refractory childhood T-cell leukaemia

难治性儿童T细胞白血病中的非典型淋巴母细胞

2025-11-120
OAAI
Off-the-shelf dual CAR-iNKT cell immunotherapy eradicates medullary and leptomeningeal high-risk KMT2A-rearranged leukemia

现成的双CAR-iNKT细胞免疫疗法可清除髓内和软脑膜高风险KMT2A重排白血病

Blood
IF23.1
2025-09-040
OAAI
PROM1/CD133 MARKS A PROLIFERATIVE STEM CELL LIKE POPULATION OF BLASTS IN KMT2A REARRANGED INFANT ALL

PROM1/CD133标记了KMT2A重排婴儿急性淋巴细胞白血病中的一种增殖性类干细胞blast群体。

2025-07-050
OAAI
Blinatumomab with De-Escalated Chemotherapy for Infant KMT2A-Rearranged B-Cell Acute Lymphoblastic Leukemia

Blinatumomab联合降阶梯化疗治疗婴儿KMT2A重排B细胞急性淋巴细胞白血病

BLOOD
IF23.1
2024-11-052
PRE
A Non-Canonical Lymphoblast in Refractory Childhood T-Cell Acute Lymphoblastic Leukemia

难治性儿童T细胞急性淋巴细胞白血病中的非经典淋巴细胞 blasts

BLOOD
IF23.1
2024-11-050
PRE
Single Cell Multimodal Framework Identifies CD84 As a Leukaemic Stem Cell Target in Paediatric AML

单细胞多模态框架将CD84鉴定为儿童AML中的白血病干细胞靶点

BLOOD
IF23.1
2024-11-050
PRE
Somatic genetic development of Wilms tumor via normal kidneys in predisposed children

易感儿童通过正常肾脏进行Wilms肿瘤的体细胞遗传发育

2024-09-050
PRE
Whole genome sequencing can reproduce all standard-of-care diagnostics for childhood cancer: Results from two national systems
2024-09-050
PRE
Whole genome sequencing provides practice-changing benefits when performed on consecutive, unselected children with suspected cancer
2024-09-050
PRE
Benefits for children with suspected cancer from routine whole-genome sequencing
2024-07-025
OAAI
Maintenance therapy for early loss of B-cell aplasia after anti-CD19 CAR T-cell therapy
2024-04-155
OAAI
Intention-to-treat outcomes utilising a stringent event definition in children and young people treated with tisagenlecleucel for r/r ALL through a national access scheme
2024-04-150
OAAI